RecallRadar

FDA Drug recall D-1584-2014

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only

On 2014-09-24 the FDA classified a Class III recall of Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only by Taro Pharmaceuticals U, citing failed Content Uniformity Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1584-2014
ClassificationClass III
Statusterminated
Initiated2014-08-25
Published2014-09-24
Last updated2026-09-13 11:51 UTC
CompanyTaro Pharmaceuticals U
DistributionCA, HI, IL, MS, NH, OH, TX

Product

Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.

Reason

Failed Content Uniformity Specifications.

Identifiers

ndc51672-4027-1
ndc51672-4027-3
ndc51672-4027-7
ndc51672-4027-0
ndc51672-4028-1
ndc51672-4028-3
ndc51672-4028-7
ndc51672-4028-0
ndc51672-4029-1
ndc51672-4029-3
ndc51672-4029-7
ndc51672-4029-0
ndc51672-4030-1
ndc51672-4030-3
ndc51672-4030-7
ndc51672-4030-0
ndc51672-4031-1
ndc51672-4031-3
ndc51672-4031-7
ndc51672-4031-0
ndc51672-4032-1
ndc51672-4032-3
ndc51672-4032-7
ndc51672-4032-0
ndc51672-4033-1
ndc51672-4033-3
ndc51672-4033-7
ndc51672-4033-0
ndc51672-4034-1
ndc51672-4034-3
ndc51672-4034-0
ndc51672-4035-1
ndc51672-4035-3
ndc51672-4035-0
code_infoLot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1584-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.